Per Løgstrup Poulsen

8PUBLICATIONS
32CO-AUTHORS
Time-series analysisMolecular medicineMedical infection agents (incl. prions)Molecular targetsPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|May 12, 2025
Test-retest repeatability of quantitative organ and tissue uptake using 20-minute dynamic multiparametric whole-body [18F]FDG PET/CT in patients with type 2 diabetes.

Jonathan M Baier, Kristian L Funck, Anna Dons-Jensen

|Mar 14, 2025
Colchicine mitigates arterial stiffness in high-risk patients with type 2 diabetes: a randomized placebo-controlled trial.

Jonathan M Baier, Kristian L Funck, Liv Vernstrøm

|Jul 30, 2024
Effects of semaglutide, empagliflozin and their combination on renal diffusion-weighted MRI and total kidney volume in patients with type 2 diabetes: a post hoc analysis from a 32 week randomised trial.

Liv Vernstrøm, Søren Gullaksen, Steffen S Sørensen

|Feb 06, 2023
Separate and combined effects of semaglutide and empagliflozin on kidney oxygenation and perfusion in people with type 2 diabetes: a randomised trial.

Søren Gullaksen, Liv Vernstrøm, Steffen S Sørensen

|Apr 20, 2022
Outcome and prognosis after adrenal metastasectomy: nationwide study.

Elizabeth Vlk, Andreas Ebbehoj, Frede Donskov

|Mar 21, 2022
The Socioeconomic Consequences of Cushing's Syndrome: A Nationwide Cohort Study.

Andreas Ebbehoj, Esben Søndergaard, Peter Jepsen

Pageof 2

Frequent Collaborators

5 joint publications

Kristian L Funck

5 joint publications

Esben Laugesen

4 joint publications

Søren Gullaksen

4 joint publications

Liv Vernstrøm